Verona Pharma plc Verona Pharma To Present At Jefferies 2017 Global Healthcare Conference

 
TIDMVRP 
 
 
   May 23, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) 
("Verona Pharma"), a clinical-stage biopharmaceutical company focused on 
developing and commercialising innovative therapeutics for the treatment 
of respiratory diseases with significant unmet medical needs, announced 
today that Jan-Anders Karlsson, PhD, CEO of Verona Pharma, is scheduled 
to present at the Jefferies 2017 Global Healthcare Conference. 
 
   An audio webcast of the presentation will be available on the Investors 
section of the company website, www.veronapharma.com.  A replay of the 
webcast will be made available for 90 days following the presentation. 
 
   Event: Jefferies Healthcare Conference 
 
   Date: June 8, 2017 
 
   Time: 11:30 AM EDT 
 
   Location: New York, NY 
 
   For further information, please contact: 
 
 
 
 
Verona Pharma plc                             Tel: +44 (0)20 3283 4200 
Jan-Anders Karlsson, Chief Executive Officer  info@veronapharma.com 
 
N+1 Singer (Nominated Adviser and UK Broker)  Tel: +44 (0)20 7496 3000 
Aubrey Powell / James White 
 
FTI Consulting (UK Media and Investor         Tel: +44 (0)20 3727 1000 
enquiries) 
Simon Conway / Stephanie Cuthbert /           veronapharma@fticonsulting.com 
 Natalie Garland-Collins 
 
ICR, Inc. (US Media and Investor enquiries) 
James Heins                                   Tel: +1 203-682-8251 
                                               James.Heins@icrinc.com 
Stephanie Carrington                          Tel. +1 646-277-1282 
                                               Stephanie.Carrington@icrinc.com 
 
 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Verona Pharma plc via Globenewswire 
 
 
  http://www.veronapharma.com/

(END) Dow Jones Newswires

May 23, 2017 08:30 ET (12:30 GMT)

Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024